Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tirzepatide on Skeletal Muscle in Obesity
NCT07373834Recruiting
- Sponsor
- University Medical Centre Ljubljana
- Start
- Jan 2026
- Primary completion
- Dec 2026
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, double-blind trial in obesity comparing Tirzepatide with Placebo (2 arms). Primary endpoints: Change in Body Mass and Composition at 24 weeks and Change in Quadriceps Muscle Strength at 24 weeks. Started Jan 2026; status: recruiting.
02
Drugs
03
Conditions
obesity
Beyond the preview
Go deeper on NCT07373834.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07373834.